Charles J Lowenstein1, Scott J Cameron. 1. Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA. charles_lowenstein@urmc.rochester.edu
Abstract
PURPOSE OF REVIEW: High-density lipoprotein (HDL) protects against atherosclerosis, transporting cholesterol from peripheral cells to the liver, where it is excreted into the bile. However, HDL also has prominent vascular protective effects. RECENT FINDINGS: Recent studies have uncovered mechanisms through which HDL decreases vascular inflammation, boosts nitric oxide production, and inhibits thrombosis. The discovery that dysfunctional HDL can also have proinflammatory effects has uncovered a new aspect of HDL biology. SUMMARY: Low-density lipoprotein is the primary target for drug therapy of dyslipidemias. Drugs that increase HDL also affect additional metabolic pathways. Development of selective drugs targeting key aspects of HDL metabolism may enable us to alter the composition of HDL and inhibit atherogenesis.
PURPOSE OF REVIEW: High-density lipoprotein (HDL) protects against atherosclerosis, transporting cholesterol from peripheral cells to the liver, where it is excreted into the bile. However, HDL also has prominent vascular protective effects. RECENT FINDINGS: Recent studies have uncovered mechanisms through which HDL decreases vascular inflammation, boosts nitric oxide production, and inhibits thrombosis. The discovery that dysfunctional HDL can also have proinflammatory effects has uncovered a new aspect of HDL biology. SUMMARY: Low-density lipoprotein is the primary target for drug therapy of dyslipidemias. Drugs that increase HDL also affect additional metabolic pathways. Development of selective drugs targeting key aspects of HDL metabolism may enable us to alter the composition of HDL and inhibit atherogenesis.
Authors: Melkaye G Melka; Michal Abrahamowicz; Gabriel T Leonard; Michel Perron; Louis Richer; Suzanne Veillette; Daniel Gaudet; Tomáš Paus; Zdenka Pausova Journal: PLoS One Date: 2013-12-20 Impact factor: 3.240
Authors: Tomáš Vaisar; Erica Couzens; Arnold Hwang; Michael Russell; Carolyn E Barlow; Laura F DeFina; Andrew N Hoofnagle; Francis Kim Journal: PLoS One Date: 2018-03-15 Impact factor: 3.240